ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Voluntary Organizations: ACS to consider targeting Research In Prostate Cancer

November 1, 1996

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012

Top 42 CCOPs (According To Priority Scores) Identified; Present Budget Would Draw Payline At 230

April 3, 1987